KKR & Co. Inc. (NYSE: KKR) shares rose early Thursday after the firm agreed to acquire Medicover India, a multi-specialty hospital network. The transaction marks a significant expansion of KKR's healthcare footprint in India, adding a network that operates 24 hospitals with about 4,800 beds across South and West India. Founded in 2017, Medicover India covers more than 80 clinical specialties, employs over 1,900 doctors, and serves millions of patients annually. KKR plans to invest in Medicover India’s talent, technology, infrastructure, and clinical capabilities, though financial terms were not disclosed and the deal remains subject to regulatory approvals.

The acquisition aligns with KKR's broader strategy in the healthcare sector. Globally, KKR has invested more than $20 billion in healthcare since 2004. In India specifically, the firm has previously invested across healthcare delivery, medical technology, and related services. This move deepens its operational presence in one of the world's fastest-growing healthcare markets.

Technical Outlook

At about $106.50, KKR is trading above its 20-day SMA of $100.17, 50-day SMA of $96.70, and 100-day SMA of $96.51. This positioning supports a positive short- and intermediate-term trend. The main technical test is the 200-day SMA near $106.95. A sustained move above that level could strengthen the bullish setup, while a rejection may trigger a pullback toward nearby support.

Momentum indicators also show improvement. The MACD is above its signal line with the histogram in positive territory, suggesting buying pressure is gaining strength following previous declines.

Analyst Consensus

The stock carries a Buy rating with an average price forecast of $124.83. Recent analyst actions include:

• Argus Research: Buy (Raises Target to $125.00) on Aug. 4
• TD Cowen: Hold (Raises Target to $111.00) on Aug. 3
• BMO Capital: Outperform (Raises Target to $118.00) on Aug. 3

ETF Holdings and Market Context

KKR holds significant weight in several key ETFs, meaning inflows or outflows from these funds could impact stock price movement. The Tema Listed Private Managers ETF (PRVT) holds a 5.48% weight, the Akre Focus ETF (AKRE) holds 8.16%, and the Invesco Global Listed Private Equity ETF (PSP) holds 4.70%.

Separately, TotalEnergies recently completed the sale of a 50% stake in a largely developed 1.2-gigawatt renewable energy portfolio to KKR at an enterprise value of 1.8 billion euros. These assets are located across Germany, Spain, France, and Poland. Nasdaq futures were down 0.57% while S&P 500 futures gained 0.13% at the time of reporting.

KKR & Co. Inc. (NYSE: KKR) delivered a strong second-quarter FY26 performance, reporting adjusted earnings per share (EPS) of $1.63 against an analyst estimate of $1.41. The firm’s revenue of $2.763 billion exceeded the consensus estimate of $2.569 billion, driven by robust monetization and record new capital inflows over the past 12 months. Co-CEOs Joseph Y. Bae and Scott C. Nuttall attributed the results to strong capital returns to clients, which supported the company’s highest-ever monetization quarter.

The financial strength was underpinned by significant growth in key earnings metrics. Fee Related Earnings (FRE) rose 37% year over year to $1.2 billion, while Total Operating Earnings (TOE) increased 29% year over year to $1.5 billion. In addition to the earnings beat, the Board declared a regular quarterly dividend of $0.195 per share of common stock.

Assets Under Management Growth

Assets under management (AUM) grew 16% year over year to $796 billion, with fee-paying assets under management (FPAUM) rising 15% year over year to $638 billion. The firm raised $34 billion of new capital during the quarter and deployed $24 billion. Perpetual Capital, representing 42% of total AUM, grew 16% year over year to $334 billion, aided by organic growth in Global Atlantic and inflows into K-Series vehicles.

Private Equity AUM increased 19% year over year to $255 billion, led by $10 billion of organic new capital raised during the quarter. Fundraising was primarily driven by Asian Fund V, Arctos Keystone Partners Fund I, and K-Series Private Equity. The firm invested $5 billion during the quarter, focusing on traditional private equity opportunities in North America and Asia.

Real Assets AUM rose 18% year over year to $211 billion, supported by $16 billion of organic new capital. Fundraising was driven by Helix Digital Infrastructure, K-Series Infrastructure, Asia Infrastructure III, and Global Infrastructure V. Deployment of $7 billion focused on infrastructure opportunities in the U.S. and Europe, along with Asia real estate equity and U.S. real estate credit.

Credit and Liquid Strategies AUM increased 1% sequentially and 13% year over year to $331 billion. This growth was supported by $9 billion of organic new capital raised during the quarter and $24 billion year to date, with inflows driven by high-grade asset-based finance activity, CLO issuances, and contributions from Global Atlantic.

Strategic Acquisitions

KKR completed the strategic acquisition of Arctos Partners on May 4, 2026. Arctos, a leading institutional investor in professional sports franchise stakes and asset management solutions for sponsors, had $20 billion in AUM as of June 30, 2026. The acquired entity is included within KKR’s Private Equity segment.

What the Numbers Show

The divergence between the 37% growth in Fee Related Earnings and the 29% growth in Total Operating Earnings suggests that fee income is outpacing performance-based returns in this quarter. This aligns with the reported 16% increase in total AUM, indicating that revenue growth is currently being driven more by asset base expansion than by performance fees. The acquisition of Arctos adds $20 billion to the AUM base, further reinforcing the fee-driven growth trajectory for the Private Equity segment.